retatrutide triple agonist obesity trial VisualAbstract: reduces body weight by 17.5% in patients with retatrutide phase 2 trial obesity

And that, we've found, is where the most profound and lasting transformations begin

Only semaglutide, tirzepatide, and liraglutide are FDA approved for weight loss, but all of these medications are approved to treat type 2 diabetes

An agonist is any artificially produced substance that can attach to cell receptors and perform the same function as the naturally occurring substance it is designed to mimic

To find out which supplement is right for you, we invite you to take our AI quiz designed to help you discover the best options tailored to your specific requirements

Robert Kushner: I haven't seen that paper, but what I can say which I thought you were getting to is that when we look at the categorical weight loss in all these trials, so some people lose 5%, 10%, 20%, 25% over the course of the trial, if you then stop the medication, the individuals who lost the greatest amount of body weight actually are the ones that regain it the quickest